Literature DB >> 17251344

Protocol for the use of polymerase chain reaction in the detection of intraocular large B-cell lymphoma in ocular samples.

Aires Lobo1, Narciss Okhravi, Peter Adamson, Brian J Clark, Susan Lightman.   

Abstract

To determine the usefulness of polymerase chain reaction (PCR) analyses in the diagnosis of lymphoid infiltrate cells in ocular samples, PCR was performed using oligonucleotide primers specific for immunoglobulin heavy chain rearrangement at framework 2, framework 3, and t(14;18) translocation of the bcl-2 gene. These were used to successfully generate amplicons of 220 to 230 bp, 110 to 120 bp, and 175 to 200 bp, respectively. After PCR amplification, primers directed against the t(14;18) detected 10 pg of B-cell lymphoma DNA. PCR against Fr2 and Fr3 IgH rearrangement detected 10 fg and 10 pg in the seminested PCR, respectively. Conventional pathological methods were highly accurate at establishing the correct final diagnosis in formalin-fixed, paraffin-embedded samples but were much less sensitive and predictive in cytological specimens of intraocular fluid. A combination of the three PCR reactions was an equally successful diagnostic approach on paraffin-embedded samples, whereas single PCR reactions did not significantly improve diagnosis over histopathological diagnostic techniques. Thus, a combination of PCR reactions is useful in the detection of B-cell monoclonality, aids the differentiation between lymphomatous and inflammatory infiltrates, and is more powerful as a diagnostic method than single PCR or conventional cytopathology for lymphoid infiltrates in ocular fluid aspirates.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17251344      PMCID: PMC1867432          DOI: 10.2353/jmoldx.2007.050121

Source DB:  PubMed          Journal:  J Mol Diagn        ISSN: 1525-1578            Impact factor:   5.568


  42 in total

Review 1.  Invasive posterior segment diagnostic procedures in immunosuppressed patients.

Authors:  W R Freeman; T E Schneiderman
Journal:  Int Ophthalmol Clin       Date:  1989

2.  Detection of chromosomal translocation t(14;18) within the minor cluster region of bcl-2 by polymerase chain reaction and direct genomic sequencing of the enzymatically amplified DNA in follicular lymphomas.

Authors:  B Y Ngan; J Nourse; M L Cleary
Journal:  Blood       Date:  1989-05-15       Impact factor: 22.113

3.  Vitreous aspiration needle tap in the diagnosis of intraocular inflammation.

Authors:  Aires Lobo; Susan Lightman
Journal:  Ophthalmology       Date:  2003-03       Impact factor: 12.079

4.  Molecular analysis of the t(14;18) chromosomal translocation in malignant lymphomas.

Authors:  L M Weiss; R A Warnke; J Sklar; M L Cleary
Journal:  N Engl J Med       Date:  1987-11-05       Impact factor: 91.245

5.  Detection of concurrent/recurrent non-Hodgkin's lymphoma in effusions by PCR.

Authors:  M Murphy; S Signoretti; I Nasser; B Sherburne; M Loda
Journal:  Hum Pathol       Date:  1999-11       Impact factor: 3.466

6.  An immunoglobulin heavy chain variable region gene is generated from three segments of DNA: VH, D and JH.

Authors:  P Early; H Huang; M Davis; K Calame; L Hood
Journal:  Cell       Date:  1980-04       Impact factor: 41.582

7.  Use of the polymerase chain reaction to detect B- and T-cell gene rearrangements in vitreous specimens from patients with intraocular lymphoma.

Authors:  V A White; R D Gascoyne; K E Paton
Journal:  Arch Ophthalmol       Date:  1999-06

8.  Primary intraocular lymphoma (ocular reticulum cell sarcoma) diagnosis and management.

Authors:  D H Char; B M Ljung; T Miller; T Phillips
Journal:  Ophthalmology       Date:  1988-05       Impact factor: 12.079

Review 9.  Molecular analysis of primary central nervous system and primary intraocular lymphomas.

Authors:  N Tuaillon; C C Chan
Journal:  Curr Mol Med       Date:  2001-05       Impact factor: 2.222

10.  Vitreous biopsy in uveitis of unknown cause.

Authors:  D M Carroll; R M Franklin
Journal:  Retina       Date:  1981       Impact factor: 4.256

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.